Home/Pipeline/Ophthalmic Drug-Device Combination (European Biotech)

Ophthalmic Drug-Device Combination (European Biotech)

Posterior eye problems (IVT therapies)

Regulatory Review (EMA)Active

Key Facts

Indication
Posterior eye problems (IVT therapies)
Phase
Regulatory Review (EMA)
Status
Active
Company

About Noxilizer

Noxilizer is a private company specializing in a novel nitrogen dioxide (NO2) gas sterilization platform for the life sciences industry. Its core innovation is an ultra-low temperature (10-30°C), surface-level sterilization process that addresses critical challenges with sensitive products like prefilled syringes, drug-device combinations, and sensors, where traditional methods like ethylene oxide (EO) or steam can damage products. The company operates through a dual business model of selling proprietary sterilization equipment and offering contract sterilization services, with validation projects underway with several biopharma clients for commercial products. Noxilizer's technology is positioned as a safer, faster, and more product-friendly alternative to established sterilization methods.

View full company profile

Therapeutic Areas